Literature DB >> 18725903

Is radioiodine more likely than antithyroid drugs to worsen ophthalmopathy in patients with Graves disease?

Rebecca S Bahn1.   

Abstract

Entities:  

Year:  2008        PMID： 18725903      PMCID： PMC3915049          DOI： 10.1038/ncpendmet0955

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  6 in total

Review 1.  Epidemiology and prevention of Graves' ophthalmopathy.

Authors:  Wilmar M Wiersinga; Luigi Bartalena
Journal:  Thyroid       Date:  2002-10       Impact factor: 6.568

Review 2.  Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease.

Authors:  Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

3.  Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.

Authors:  Luigi Bartalena; Lelio Baldeschi; Alison J Dickinson; Anja Eckstein; Pat Kendall-Taylor; Claudio Marcocci; Maarten P Mourits; Petros Perros; Kostas Boboridis; Antonella Boschi; Nicola Currò; Chantal Daumerie; George J Kahaly; Gerasimos Krassas; Carol M Lane; John H Lazarus; Michele Marinò; Marco Nardi; Christopher Neoh; Jacques Orgiazzi; Simon Pearce; Aldo Pinchera; Susanne Pitz; Mario Salvi; Paolo Sivelli; Matthias Stahl; Georg von Arx; Wilmar M Wiersinga
Journal:  Thyroid       Date:  2008-03       Impact factor: 6.568

Review 4.  Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.

Authors:  Shamasunder H Acharya; Alison Avenell; Sam Philip; Jennifer Burr; John S Bevan; Prakash Abraham
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-21       Impact factor: 3.478

5.  Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.

Authors:  M F Prummel; W M Wiersinga; M P Mourits; L Koornneef; A Berghout; R van der Gaag
Journal:  Arch Intern Med       Date:  1990-05

Review 6.  The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation.

Authors:  Terry J Smith
Journal:  Autoimmunity       Date:  2003 Sep-Nov       Impact factor: 2.815
  6 in total
  1 in total

Review 1.  Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis.

Authors:  H X Li; N Xiang; W K Hu; X L Jiao
Journal:  J Endocrinol Invest       Date:  2016-05-24       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.